CompletedNCT01312272
Acute Intranasal Oxytocin and Social Cognition in Schizophrenia
About this title
Read the official source — NCT01312272Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- Los AngelesSee all locations and recruitment
Study information
Study start dateApril 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- VA Greater Los Angeles Healthcare System
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01312272
- Official title
Show the full official title
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Greater Los Angeles Healthcare System.
Did this study involve medication?
Yes. The study involved medication, including Oxytocin and Inactive placebo nasal spray.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
